Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 16, 2011 16:27 ET | Source: Cytomedix, Inc.

Cytomedix Reports First Quarter Financial Results

GAITHERSBURG, Md., May 16, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the Company), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
May 11, 2011 07:47 ET | Source: Cytomedix, Inc.

Cytomedix to Host First Quarter 2011 Financial Results Conference Call on Tuesday, May 17, 2011

GAITHERSBURG, Md., May 11, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
May 02, 2011 08:00 ET | Source: Cytomedix, Inc.

Cytomedix Retires All Angel Acquisition Debt With New Loan and Equity Financing

GAITHERSBURG, Md., May 2, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
April 13, 2011 08:00 ET | Source: Cytomedix, Inc.

Cytomedix Announces Multiple Presentations at the 24th Annual Symposium on Advanced Wound Care and Wound Healing Society

GAITHERSBURG, Md., April 13, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
March 30, 2011 17:16 ET | Source: Cytomedix, Inc.

Cytomedix Reports 2010 Fourth Quarter and Full Year Financial Results

GAITHERSBURG, Md., March 30, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
March 17, 2011 16:05 ET | Source: Cytomedix, Inc.

Cytomedix Announces Issuance of Notice of Allowance for Patent Covering Separation Device for Proposed New AutoloGel System

GAITHERSBURG, Md., March 17, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company" or "Cytomedix"), a leading developer of biologically active regenerative therapies for wound care and...
March 16, 2011 08:00 ET | Source: Cytomedix, Inc.

Cytomedix to Host Fourth Quarter and Full Year 2010 Financial Results Conference Call on Thursday, March 31, 2011

GAITHERSBURG, Md., March 16, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
March 10, 2011 08:27 ET | Source: Cytomedix, Inc.

Cytomedix Appoints Gary R. Otto as Director of National Accounts

GAITHERSBURG, Md., March 10, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company" or "Cytomedix"), a leading developer of biologically active regenerative therapies for wound care and...
February 15, 2011 08:14 ET | Source: Cytomedix, Inc.

Cytomedix to Present at the Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on February 17

GAITHERSBURG, Md., Feb. 15, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company" or "Cytomedix"), a leading developer of biologically active regenerative therapies for wound care,...
February 10, 2011 08:00 ET | Source: Cytomedix, Inc.

Cytomedix Receives CE Mark for Angel and activAT

GAITHERSBURG, Md., Feb. 10, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company" or "Cytomedix") today announced that the Company has been issued a CE marking certification for its...